Ed Zhang

Co-Founder & Chief Executive Officer Overland Pharmaceuticals

Seminars

Thursday 3rd December 2026
Navigating Global Development Pathways Across US, Europe, & China to Maximize Competitiveness in Autoimmune Cell Therapy
3:30 pm
  • Comparing cross-border development pathways to accelerate speed-to-clinic and improve program execution
  • Evaluating partnership versus independent strategies to balance access and IP control
  • Addressing regulatory and geopolitical challenges to strengthen global competitiveness
Ed Zhang